s at 0 month*                                            0.00           \<0.000   Sleep difficulties (at T0)                                                                       Total effect                           0.00          0.00                                     \<0.000   Direct effect                          0.00          0.00                                     \<0.000   Indirect effect via mediator                                                                     PTS symptoms (at T0)                   0.00          0.00   0.00; 0.00                                                                                                                            *DV: 